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ABSTRACT 
 
Associations Between Chronic Pain and Use of  
Pharmacotherapy for Smoking Cessation. (August 2012) 
Emily Lynn Zale, B.A., University of Rochester 
Chair of Advisory Committee: Dr. Joseph W. Ditre 
 
Chronic pain and tobacco dependence are two highly prevalent and comorbid 
conditions. The rate of smoking among persons in pain may be greater than twice the 
rate observed in the general population. Smokers tend to experience more adverse pain-
treatment outcomes than do nonsmokers, and there is mounting evidence to suggest that 
smokers with comorbid pain disorders may have more difficulty abstaining from 
tobacco. The main goal of the current study was to examine cross-sectional relations 
between chronic pain status and past use of pharmacotherapy for smoking cessation. We 
also tested associations between chronic pain status and frequency of past quit attempts. 
Data were derived from a nationally-representative survey of households in the 
continental United States. After adjusting for sociodemographic factors, substance use, 
mood and anxiety disorders, and number of attempts to quit smoking, smokers with 
chronic pain were found to be 1.67 times more likely to endorse past use of 
pharmacotherapy for smoking cessation, relative to smokers with no chronic pain. 
Chronic pain status was not associated with number of past attempts to quit smoking. 
These data suggest that smokers with chronic pain are motivated to quit smoking, and 
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may be particularly amenable to pharmacologic intervention. Results are discussed with 
regard to clinical implications and directions for future research. 
 v 
TABLE OF CONTENTS 
 
              Page 
ABSTRACT ..............................................................................................................  iii 
TABLE OF CONTENTS ..........................................................................................  v 
LIST OF TABLES ....................................................................................................  vi 
1. INTRODUCTION ...............................................................................................  1 
  1.1 Introduction to Tobacco Smoking and Chronic Pain ...........................  1 
  1.2 The Effects of Smoking on Pain ..........................................................  3 
  1.3 The Effects of Pain on Smoking ..........................................................  6 
  1.4 Reciprocal Relation Between Pain and Smoking .................................  7 
  1.5 Pain and Smoking Cessation ................................................................  7 
  1.6 Pharmacologic Treatments for Tobacco Dependence ..........................  8 
  1.7 Summary and Current Investigation ....................................................  9 
  
2. METHOD ............................................................................................................  11 
  2.1 Data Source ..........................................................................................  11 
  2.2 Measures ...............................................................................................  11 
  2.3 Data Analytic Approach .......................................................................  12 
3. RESULTS ............................................................................................................  14 
  3.1 Sample Characteristics .........................................................................  14 
  3.2 Use of Pharmacotherapy for Smoking Cessation .................................  14 
  3.3 Past Attempts to Quit Smoking ............................................................  16 
   
4. SUMMARY AND CONCLUSIONS ..................................................................  19 
REFERENCES ..........................................................................................................  22 
VITA .........................................................................................................................  37 
 vi 
LIST OF TABLES 
 
                                                                                                                                       Page 
Table 1 Sociodemographic Characteristics, Substance Use and Mood  
 Disorders, and Use of Pharmacotherapy for Smoking Cessation  
 by Chronic Pain Status ..............................................................................  15 
 
Table 2 Multiple Logistic Regression Analysis of the Association  
 Between Chronic Pain Status and Past Use of Any  
 Pharmacotherapy to Cut Down or Quit Smoking .....................................  17 
 
Table 3 Odds of Past Use of Pharmacotherapy to Cut Down or Quit  
Smoking by Chronic Pain Sub-Type ..........................................................  18 
 1 
1. INTRODUCTION 
 
1.1 Introduction to Tobacco Smoking and Chronic Pain 
1.1.1 Tobacco smoking 
Tobacco use remains the leading preventable cause of mortality in the United 
States, resulting in 443,000 deaths and $193 billion in health-related economic losses 
each year (CDC, 2008). Smoking has been identified as a causal agent in multiple forms 
of cancer, cardiovascular diseases, and respiratory diseases (DHHS, 2004). Despite 
known health risks, nearly 21% (47 million) of adults in the United States are current 
smokers. The prevalence of cigarette smoking has remained stable since 2004 (CDC, 
2004, 2010), which may indicate that there are subpopulations of smokers who face 
unique challenges to quitting (Borrelli, 2010). To that end, smokers with comorbid 
medical conditions (e.g., chronic pain) have been identified as important targets for 
smoking cessation interventions (Fiore et al., 2008).  
1.1.2 Chronic pain 
Pain is a national health concern that affects up to 43% (116 million) of 
American adults (IOM, 2011; Tsang et al., 2008). Pain motivates at least 50% of 
physician visits each year (Mayo Clinic, 2001; Turk & Melzack, 2011), and according to 
recent estimates by the National Academies of Sciences, pain is responsible for up to 
$635 billion annually in direct health care expenditures and lost productivity (IOM, 
2011). Chronic pain can be differentiated from acute pain by duration, intensity, 
____________ 
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and associated disability, yet researchers have not reached a consensus regarding a 
definition that encompasses all domains (Turk & Melzack, 2011). Therefore, chronic 
pain is typically distinguished from acute pain by duration, with most studies utilizing 
cutoffs ranging from 3-6 months (e.g., Ekholm, Gronbaek, Peuckmann, & Sjogren, 
2008; Jakobsson, 2008; Strine & Hootman, 2007; Zvolensky, McMillan, Gonzalez, & 
Asmundson, 2010). In addition to physical impairment and disability, chronic pain has 
been associated with increased absence from work and unemployment, reduced 
participation in social or recreational activities, lower perceived social support, and 
increased suicidality (Braden & Sullivan, 2008; Carr & Moffett, 2005; Closs, 2009; 
Ilgen, Zivin, McCammon, & Valenstein, 2008).   
1.1.3  Comorbidity between pain and smoking  
The prevalence of smoking among persons with chronic pain is approximately 
twice that observed in the general population. Reports of smoking prevalence among 
clinical pain samples indicate 49-68% of treatment seeking pain patients are current 
smokers (Hooten, Shi, Gazelka, & Warner, 2011; Jamison, Stetson, & Parris, 1991; 
Michna et al., 2004). Epidemiological studies have also reported that persons with 
chronic pain were almost twice as likely to be smokers, even after controlling for 
relevant demographic characteristics and comorbid conditions (e.g., Strine & Hootman, 
2007; Zvolensky et al., 2010). For example, in a nationally representative sample of 
adults in the United States, 42% of persons with medically-unexplained chronic pain 
were current smokers, and persons with chronic back or neck pain were almost twice as 
likely (OR = 1.95, 95% CI = 1.41-2.68) to meet DSM-IV criteria for nicotine 
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dependence, relative to persons without pain (Zvolensky, McMillan, Gonzalez, & 
Asmundson, 2009). Similar prevalence rates and odds ratios that further substantiate the 
comorbidity of pain and smoking in nationally representative samples have been 
reported in Denmark (Ekholm et al., 2008), Norway (Brage & Bjerkedal, 1996), Sweden 
(Hagg, Fritzell, & Nordwall, 2002; Jakobsson, 2008), Canada (Zvolensky et al., 2010), 
and the United Kingdom (Palmer, Syddall, Cooper, & Coggon, 2003).  
1.2 The Effects of Smoking on Pain 
1.2.1 Painful conditions associated with smoking  
Tobacco smoking has been associated with the onset and progression of 
numerous painful medical conditions, and there is recent evidence that smoking may be 
a unique causal agent in the development of rheumatoid arthritis and low back pain (e.g., 
Shiri, Karppinen, Leino-Arjas, Solovieva, & Viikari-Juntura, 2010; Sugiyama et al, 
2010). Smoking has been associated with arthritis disease progression and severity (e.g., 
Saag et al., 1997), and a recent meta-analysis demonstrated a dose-response relation 
between back pain and the number of cigarettes smoked per day (Shiri et al., 2010). 
Smoking has also been associated with the prevalence/severity of chronic headaches 
(Aamodt, Stovner, Hagen, Brathen, & Zwart, 2006; Payne et al., 1991), painful oral 
diseases (Johnson & Slach, 2001; Winn, 2001), fibromyalgia (e.g., Lee et al., 2010), 
menstrual pain (Gold et al., 2007), pregnancy related pelvic pain (Biering, Aagaard 
Nohr, Olsen, Nybo Andersen, & Juhl, 2010), Buerger’s diease (Quintas & Albuquerque, 
2008), and pain associated with HIV (Patel et al., 2006), osteoarthritis (Amin et al., 
2007), and sickle cell disease (Cohen, DeBaun, Blinder, Strunk, & Field, 2010).  
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1.2.2 Smoking and pain treatment  
There is evidence that, relative to nonsmokers, smokers are less likely to 
complete treatment for chronic pain, and more likely to report post-treatment affective 
distress and health-role limitations (Hooten et al., 2009). Smoking has been shown to 
impair the efficacy of several treatments for rheumatoid arthritis (e.g., Harty & Veale, 
2010), and smokers are more likely to experience adverse outcomes following surgical 
pain interventions (Glassman et al. 2007). There is also evidence that smokers are more 
likely than nonsmokers to hold multiple opioid medication prescriptions (Skurtveit, 
Furu, Selmer, Handal, & Tverdal, 2010), and that smokers tend to use greater quantities 
of analgesic medications (Hooten, Shi, et al., 2011) for longer periods of time (Krebs et 
al., 2010). Finally, it appears that smokers are less likely than nonsmokers to return to 
work following treatment for chronic pain (Fishbain et al., 2008). 
1.2.3 Pain-inhibitory effects of nicotine in animals 
Although smoking contributes to the development and worsening of pain, there is 
paradoxical evidence that nicotine may also have acute pain-inhibitory effects. In animal 
models, nicotine administered subcutaneously has been shown to inhibit pain induced by 
thermal and mechanical stimulation (e.g., Aceto, Bagley, Dewey, Fu, & Martin, 1986; 
Block, Chin, Wu, & Zbuzek, 1993; Rowley & Flood, 2008; Rowley, Payappilly, Lu, & 
Flood, 2008; Tripathi, Martin, & Aceto, 1982). Similar results were also obtained when 
nicotine was administered via cigarette smoke in an environmental chamber (Anderson 
et al., 2004; Simons et al., 2005). However, there is evidence that the acute pain-
inhibitory effects of nicotine may subside following chronic nicotine administration. 
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Chronic exposure to both subcutaneous nicotine and tobacco smoke have been shown to 
result in nicotine tolerance, and a decline in previously observed analgesic effects 
(Carstens, Anderson, Simons, Carstens, & Jinks, 2001; Galeote, Kieffer, Maldonado, & 
Berrendero, 2006; Simons et al., 2005).  
1.2.4 Pain-inhibitory effects of nicotine in humans  
Clinical and laboratory studies have also demonstrated that acute nicotine 
administration may have pain-inhibitory effects in humans. For example, clinical 
evidence indicates that nicotine may reduce post-operative pain and analgesic 
requirements among nonsmokers, although these effects have not been demonstrated in 
smokers (e.g., Habib et al., 2008; Hong, Conell-Price, Cheng, & Flood, 2008; Olson, 
Hong, Conell-Price, Cheng, & Flood, 2009; Turan et al., 2008). Laboratory studies have 
also demonstrated that acute nicotine administration may increase pain tolerance and 
threshold ratings (e.g., Perkins, Grobe, Stiller, & Scierka, 1994; Pomerleau, Turk, & 
Fertig, 1984; Silverstein, 1982). However, a substantial number of studies (n=8) have 
not observed such effects (Jarvik, Caskey, Rose, Herskovic, & Sadeghpour, 1989; Knott, 
1990; Knott & De Lugt, 1991; Mueser, Waller, Levander, & Schalling, 1984; Shiffman 
& Jarvik, 1984; Sult & Moss, 1986; Unrod, Kassel, & Robinson, 2004; Waller, 
Schalling, Levander, & Edman, 1983). To integrate these findings, we recently 
conducted a meta-analysis (Ditre, Heckman, Zale, & Herrick, in preparation) which 
revealed a small, but positive effect of nicotine on both pain tolerance (Hedge’s g = .26) 
and threshold (Hedge’s g = .27).  
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1.3 The Effects of Pain on Smoking 
1.3.1  Cross-sectional evidence  
Researchers have proposed that the avoidance, relief, or both, of pain is a 
powerful behavioral reinforcer that may be an important mechanism in the maintenance 
of tobacco smoking and nicotine dependence (Fertig, Pomerleau, & Sanders, 1986; 
Fishbain et al., 2007; Jarvik et al., 1989; Pomerleau, 1986; Silverstein, 1982; Zvolensky 
et al., 2009). Indeed, a growing body of research provides evidence that pain may be a 
potent motivator of smoking behavior. For example, smokers receiving pain treatment 
consistently endorse smoking in response to pain (Hooten, Vickers, et al., 2011; Jamison 
et al., 1991). In a qualitative study of smokers with chronic pain, participants reported 
that smoking provides distraction from both physical pain and pain-related distress, and 
they identified distraction as a primary motive of their smoking behavior (Hooten, 
Vickers, et al., 2011). Multiple studies have also observed a dose-response relation 
between pain intensity and daily cigarette consumption, such that greater pain intensity 
was associated with increased cigarette consumption (e.g., Hahn, Rayens, Kirsh, & 
Passik, 2006; Riley, Tomar, & Gilbert, 2004; Saag et al., 1997). 
1.3.2  Experimental evidence  
Ditre and Brandon (2008) conducted the first laboratory study designed to test 
the effects of pain on smoking motivation. Relative to controls, smokers who underwent 
experimental pain induction reported greater urge and demonstrated decreased latency to 
smoke. In a follow-up study, Ditre et al. demonstrated that the relationship between pain 
and smoking motivation can be successfully manipulated by invoking social-cognitive 
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constructs (Ditre, Heckman, Butts, & Brandon, 2010). Specifically, pain-induced urge to 
smoke was attenuated by use of a pain-coping strategy (i.e., distraction), and similar 
effects were observed when smokers’ expectations for smoking-related pain relief were 
challenged prior to pain induction. These results indicate that pain-coping and smoking-
related outcome expectancies may be important targets of tailored smoking cessation 
interventions for smokers with comorbid pain disorders.  
1.4 Reciprocal Relation Between Pain and Smoking 
While smoking has been associated with the cause and course of chronic pain 
conditions, there is also reason to believe that pain motivates continued smoking 
behavior. By integrating findings from both directions of empirical inquiry, Ditre & 
Brandon (2008) hypothesized a reciprocal relation between pain and smoking that 
interacts in the manner of a positive feedback loop, with the end result being increased 
pain and the maintenance of tobacco dependence. Extrapolating from the hypothesized 
model, there is reason to predict that smokers with chronic pain may experience more 
difficulty abstaining from tobacco. 
1.5 Pain and Smoking Cessation  
Consistent with evidence that pain motivates smoking, there is also reason to 
believe that pain may serve as a significant barrier to smoking cessation. For example, 
smokers in pain tend to report greater difficulty and less confidence in quitting relative 
to their pain-free counterparts (Ditre, Zale, Heckman, Brandon, in preparation). Patients 
undergoing pain treatment have also reported limited confidence in their ability to 
additionally cope with the stress of quitting smoking (Hooten, Vickers, et al., 2011). 
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Finally, there is longitudinal evidence that smokers with a history of migraine pain were 
more likely to have tried unsuccessfully to quit smoking than were persons without 
migraine pain (Waldie, McGee, Reeder, & Poulton, 2008).  
Based on results from experimental studies conducted in animals and humans, 
there is reason to believe that pain may precipitate relapse to smoking. Animal models of 
stress-induced relapse (Sinha, Shaham, & Heilig, 2011) have demonstrated that 
following extinction of nicotine-self administration, exposure to a painful stressor (e.g., 
electric shock) reinstated drug-seeking behavior (Bruijnzeel, Prado, & Isaac, 2009; 
Zislis, Desai, Prado, Shah, & Bruijnzeel, 2007). In addition, a recent human 
experimental study demonstrated that relapse to smoking was predicted by greater pain 
reactivity prior to quitting (Nakajima & al'Absi, 2011). Taken together, evidence from 
animal and human studies suggests that smokers may be vulnerable to pain-induced 
relapse to smoking. 
1.6 Pharmacologic Treatments for Tobacco Dependence 
According to the Clinical Practice Guidelines for Treating Tobacco Use and 
Dependence, all persons who are attempting to quit smoking should be encouraged to 
use one or more FDA-approved pharmacologic aids (Fiore et al., 2008). Current first-
line smoking cessation agents include five forms of nicotine replacement therapy (NRT), 
the antidepressant bupropion (Zyban), and the partial nicotine agonist/antagonist 
varenicline tartrate (Chantix). Each of these medications has demonstrated efficacy in 
improving smoking cessation outcomes, essentially doubling the rates of successful 
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quitting, relative to placebo (e.g., Fiore et al., 2008; Huang, Li, Yang, Jiang, & Wu, 
2012).    
1.7 Summary and Current Investigation   
Tobacco dependence and chronic pain are two highly prevalent and comorbid 
conditions that engender substantial burdens upon individuals and health care systems. 
Although tobacco smoking remains the leading preventable cause of morbidity and 
mortality in the United States, nearly 20% of American adults continue to smoke 
tobacco (CDC, 2011). Like smoking, chronic pain is a critical national health problem 
that affects over 100 million adults, with an annual economic cost of up to $560 billion 
(IOM, 2011). Clinical and epidemiological data indicate that the prevalence of tobacco 
smoking among persons in pain may be greater than twice the rate observed in the 
general population (Ditre, Brandon, Zale, & Meagher, 2011; Shi, Weingarten, Mantilla, 
Hooten, & Warner, 2010; Zvolensky et al., 2009).  
Smoking has been identified as a unique causal agent in the onset and 
progression of chronic pain (e.g., Shiri et al., 2010; Sugiyama et al., 2010), and there is 
some evidence that smokers (relative to nonsmokers) experience more severe pain (e.g., 
Ditre et al., 2011) and poorer pain-treatment outcomes (Fishbain et al., 2008; Glassman 
et al., 2007). Conversely, pain has been shown to increase desire to smoke (Ditre & 
Brandon, 2008; Ditre et al., 2010), greater pain has been associated with increased 
cigarette consumption (e.g., Hahn et al., 2006; Riley et al., 2004; Saag et al., 1997), and 
pain patients have endorsed tobacco smoking as a means of coping with pain (Hooten, 
Vickers et al., 2011; Jamison et al., 1991; Patterson et al., 2012). Consistent with these 
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observations, Ditre et al. (2011) proposed a reciprocal model of pain and smoking that is 
hypothesized to act in the manner of a positive feedback loop, resulting in greater pain, 
increased smoking, and the maintenance of tobacco dependence. 
With regard to smoking cessation, researchers have suggested that specific 
subpopulations of smokers may experience unique challenges when attempting to quit 
(e.g., Borrelli, 2010), and there is mounting evidence that recurring pain may present a 
significant barrier to smoking cessation. Smokers in pain tend to endorse less confidence 
in quitting (Hooten, Vickers, et al., 2011), greater difficulty when attempting to quit 
(Waldie et al., 2008), and poorer abstinence-related outcomes (Waldie et al., 2008). 
Interestingly, there is reason to believe that pain may not adversely influence motivation 
to quit smoking. For example, Hahn et al. (2006) observed no difference in self-reported 
motivation to quit as a function of past-week pain status.  
Given evidence of complex interactions and significant comorbidity between 
pain and tobacco smoking, it is important to examine how approaches to quitting may 
differ between smokers with and without chronic pain. We are not aware of any previous 
studies that examined associations between chronic pain and either the likelihood of 
having used pharmacotherapy for smoking cessation, or the frequency of having 
engaged a serious quit attempt. Specifically, we hypothesized that smokers who 
endorsed any chronic pain (relative to no chronic pain) would be more likely to have 
utilized pharmacologic aids for smoking cessation. Secondary analyses were conducted 
to examine past use of pharmacotherapy across chronic pain sub-types. We also sought 
to explore associations between chronic pain status and frequency of past quit attempts.  
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2. METHOD 
2.1 Data Source 
Data were derived from the National Comorbidity Survey-Replication (NCS-R), 
a nationally-representative, two-part survey of households in the continental United 
States. Face-to-face interviews were conducted with 9,282 English-speaking adults 
between February 2001 and April 2003. Part I of the survey collected demographic 
information and screened for psychiatric disorders, and Part II assessed smoking history 
and health status. A detailed description of recruitment, survey administration, and 
weighting procedures is provided by Kessler et al. (2004). Analyses were restricted to 
respondents who endorsed current smoking (N = 1,636). 
2.2 Measures 
2.2.1 Chronic pain status  
Participants were asked: “Have you ever had any of the following: arthritis or 
rheumatism; chronic back or neck problems; frequent or severe headaches; any other 
chronic pain?” Participants were also asked whether they ever had medically-
unexplained chronic pain, which was defined as pain lasting at least six months that 
interfered with daily activities, caused emotional distress, and for which there was no 
apparent physical cause. Participants provided separate (yes/no) responses for each type 
of pain, and these responses were combined to generate a dichotomous "chronic pain 
status" (any/none) variable.  
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2.2.2 Past utilization of pharmacotherapy for smoking cessation 
Participants were asked: “Have you ever in your life used any of the following 
types of treatments to help you cut down or quit smoking: nicotine patch or nicotine 
gum; a prescription medicine?” Participants provided separate (yes/no) responses for 
nicotine patch/gum and prescription medication, which were combined to create a 
dichotomous "any pharmacotherapy/no pharmacotherapy" variable.   
2.2.3 Frequency of past attempts to quit smoking 
Participants were asked to report the number of different times they had made a 
serious attempt to quit smoking. Responses were open ended and recorded as a 
continuous variable.  
2.2.4 Lifetime substance use and mood disorders  
 The World Health Organization’s Composite International Diagnostic Interview 
(WHO-CIDI; Kessler & Ustun, 2004) was used to assess lifetime history of Alcohol 
Abuse/Dependence, Drug Abuse/Dependence (excluding nicotine), Major Depressive 
Disorder, Dysthymia, and Generalized Anxiety Disorder. Each disorder was assessed 
individually using Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) criteria. Alcohol and Drug Abuse/Dependence were combined to create a 
dichotomous (yes/no) “substance use disorder” variable. Major Depressive Disorder and 
Dysthymia were combined to generate a dichotomous “mood disorder” variable. 
2.3 Data Analytic Approach  
Multiple logistic regression was conducted to test the hypothesized association 
between chronic pain status and past use of pharmacotherapy for smoking cessation. 
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Secondary analyses tested relations between chronic pain sub-types and past use of 
either NRT or prescription cessation medications. Linear regression was conducted to 
explore the association between chronic pain status and number of past attempts to quit 
smoking. All analyses incorporated weights as provided by NCS-R, and employed the 
Taylor series linearization method to adjust for the complex sampling design (Wolter, 
1985). Analyses controlled for the influence of relevant sociodemographic (age, gender, 
race/ethnicity, education, income, and marital status) and psychiatric (lifetime substance 
use, anxiety, and mood disorders) factors, and number of past quit attempts. 
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3. RESULTS 
3.1 Sample Characteristics  
Survey respondents were predominantly white (73%), with an average age of 
41.30 years (SD = 15.99). Gender was fairly evenly distributed (52% male), and the 
majority of participants did not meet criteria for lifetime substance use (70%), anxiety 
(89%), or depressive disorders (80%). With regard to smoking history, respondents 
reported smoking an average of 16 cigarettes per day (SD = 12.03) for a mean duration 
of 20 years (SD = 15.18). Smokers also reported having made an average of 6.04 (SD = 
41.29) serious attempts to cut down or quit smoking in their lifetime. Less than half 
(41%) of respondents endorsed having ever used any pharmacological aids to cut down 
or quit smoking. Chi-square and linear regression analyses revealed that smokers who 
endorsed any chronic pain (relative to no chronic pain) tended to be older, married, 
female, and white (see Table 1). Smokers with comorbid chronic pain were also more 
likely to have been diagnosed with a lifetime mood or anxiety disorder (both ps < .001). 
3.2 Use of Pharmacotherapy for Smoking Cessation 
As hypothesized, analyses revealed a significant, positive relation between 
chronic pain status and past use of pharmacotherapy to cut down or quit smoking (see 
Table 2). Specifically, smokers who endorsed any chronic pain were 67% more likely to 
have used any pharmacotherapy for smoking cessation, when compared to smokers with 
no chronic pain (95% CI = 1.24-2.24, p < .001). Follow-up analyses indicated that 
smokers with comorbid pain were more likely to have used nicotine patch or gum (AOR 
= 1.56, 95% CI = 1.18-2.06, p < .01), but not prescription cessation medications (AOR =  
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Table 1  
Sociodemographic Characteristics, Substance Use and Mood Disorders, and Use of 
Pharmacotherapy for Smoking Cessation by Chronic Pain Status   
 
  No Chronic  
Pain 
Any Chronic 
Pain 
Total  
Sample 
  n (%) n (%) n (%) 
Gender**    
 Male 311 (56.6%) 451 (48.4%) 762 (51.8%) 
 Female 279 (43.4%) 584 (51.6%) 863 (48.2%) 
     
Race/Ethnicity    
 White* 428 (69.6%) 769 (75.2%) 1197 (72.9%) 
 Black 70 (9.5%) 136 (4.3%) 206 (11.2%) 
 Hispanic*** 57 (15.9%) 57 (8.3%) 114 (11.4%) 
 Other 35 (5.1%) 73 (4.2%) 108 (4.5%) 
     
Education    
 0-11 Years 122 (24.7%) 244 (25.7%) 366 (25.3%) 
 12 Years 115 (39.4%) 383 (38.7%) 609 (39.0%) 
 12-15 Years 169 (25.2%) 279 (24.9%) 448 (25.0%) 
 ≥16 Years 73 (10.8%) 129 (10.7%) 202 (10.7%) 
     
Marital Status    
 Married/Cohabitating** 283 (45.4%) 547 (52.6%) 830 (49.6%) 
 Divorced/Separated/Widowed* 113 (20.8%) 289 (26.7%) 402 (24.3%) 
 Never Married* 194 (33.8%) 199 (20.6%) 393 (26.1%) 
    
Substance Use Disorder 211 (28.4%) 385 (31.0%) 596 (29.9%) 
    
Mood Disorder*** 158 (15.7%) 325 (23.4%) 483 (20.2%) 
    
Generalized Anxiety Disorder*** 69 (6.2%) 198 (14.4%) 267 (11%) 
    
Use of Pharmacotherapy    
 Any Pharmacotherapy*** 122 (31.8%) 329 (46.0%) 451 (40.6%) 
 Nicotine Patch/Gum*** 108 (28.6%) 296 (41.2%) 404 (36.4%) 
 Prescription  570 (13.4%) 130 (17.8%) 179 (16.1%) 
 M (SD) M (SD) M (SD) 
Age*** 38.22 (15.72) 43.48 (15.84) 41.30 (15.99) 
Income 50,497(43,426) 49,217 
(44,035) 
49,908 
(43,748) 
Note. Inconsistencies between n and % are due to effects of the weighting procedure. All ns 
were unweighted. All %s were weighted.  
** p < .01. *** p < .001.  
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1.27, 95% CI = 0.85-1.90, p = .26). Secondary analyses revealed that 
arthritis/rheumatism, chronic back/neck pain, and frequent/severe headaches were each 
individually associated with a greater likelihood of having used any pharmacotherapy to 
cut down or quit smoking (all ps < .05; see Table 3). Again, these associations were 
primarily driven by past use of nicotine patch or gum (all ps < .05), but not prescription 
medications (all ps > .12). 
3.3 Past Attempts to Quit Smoking 
We observed no evidence of an association between chronic pain status and 
number of past attempts to cut down or quit smoking (b = 3.16, t(1072) = 1.62, p = .11). 
Similar null findings were observed for each chronic pain sub-type, including 
arthritis/rheumatism (p = .53), chronic back/neck pain (p = .88), frequent/severe 
headaches (p = .68), other chronic pain (p = .19), and medically-unexplained chronic 
pain (p = .52). 
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Table 2 
Multiple Logistic Regression Analysis of the Association Between Chronic Pain Status 
and Past Use of Any Pharmacotherapy to Cut Down or Quit Smoking 
 
   Past Use of Any Pharmacotherapy 
   β SE Wald’s χ2  OR 95% CI p 
Primary Predictor 
 Chronic Pain Status  0.51 0.15 11.57 1.67 1.24-2.24 < .001 
         
Covariates 
 Gender (male) -0.24 0.17 1.98 0.79 0.56-1.10 .16 
        
 Race/Ethnicity       
  Other – – – – – – 
  White -0.14 0.40 0.12 0.87 0.40-1.90 .73 
  Black -1.02 0.46 5.02 0.36 0.15-0.88 .03 
  Hispanic -1.28 .53 5.82 0.28 0.10-0.79 .02 
         
 Education       
  0-11 years – – – – – – 
  12 years 0.35 0.17 4.04 1.42 1.01-1.99 .04 
  13-15 years 0.23 0.25 0.89 1.26 0.78-2.06 .35 
  ≥16 Years 0.51 0.31 2.76 1.67 0.91-3.03 .10 
         
 Marital Status       
  Married – – – – – – 
  Divorced/Widowed/Separated 0.03 0.24 0.02 1.03 0.64-1.66 .90 
  Never Married -0.29 0.26 1.19 0.75 0.45-1.26 .28 
         
 Substance Use Disorder 0.48 0.15 10.64 1.61 1.21-2.14 .001 
        
 Mood Disorder 0.00 .22 0.00 1.00 0.65-1.53 .99 
        
 Generalized Anxiety Disorder 0.27 0.19 1.98 1.21 0.90-1.91 .16 
        
 Age 0.01 0.01 3.76 1.01 1.00-1.03 .05 
        
 Income 0.00 0.00 1.55 1.00 1.00-1.00 .21 
        
 Number of Past Quit Attempts 0.00 0.00 0.30 1.00 0.99-1.01 .58 
       
Overall Model Evaluation χ2 df p    
 Likelihood Ratio Test 85.19 16 < .001    
 Score Test 79.69 16 < .001    
 Wald Test  208.51 16 < .001    
Note. All degrees of freedom (df ) = 1, unless otherwise noted. SE = standard error. OR = odds ratio. 
CI = confidence interval. 
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Table 3  
Odds of Past Use of Pharmacotherapy to Cut Down or Quit Smoking by Chronic Pain 
Sub-Type 
 
 Past Use of Pharmacotherapy 
 Any Pharmacotherapy 
Nicotine 
Patch/Gum 
Prescription 
Medication 
 AOR (95% CI) AOR (95% CI) AOR (95% CI) 
Any Chronic Pain  1.67 (1.24-2.24)*** 1.56 (1.18-2.06)** 1.27 (0.84-1.90) 
Arthritis/Rheumatism  1.50 (1.05-2.13)* 1.55 (1.13-2.14)* 1.36 (0.88-2.09) 
Back/Neck  1.43 (1.06-1.93)* 1.49 (1.13-1.97)** 0.93 (0.71-1.23) 
Headaches  1.62 (1.15-2.26)** 1.54 (1.07-2.23)* 1.20 (0.82-1.77) 
Medically-Unexplained  1.42 (0.75-2.69) 1.56 (0.79-3.07) 1.50 (0.97-2.32) 
Other  1.09 (0.70-1.70) 1.16 (0.74-1.84) 1.46 (0.90-2.39) 
Note. AOR = odds ratio adjusted for age, gender, race/ethnicity, education, income, marital 
status, and substance use, mood and anxiety disorders. CI = confidence interval.  
* p < .05.  ** p < .01. *** p < .001.  
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4. SUMMARY AND CONCLUSIONS 
Results indicated that smokers with chronic pain were more likely to have 
utilized pharmacotherapy for smoking cessation than were smokers with no chronic 
pain. Similar associations were observed between individual chronic pain sub-types and 
the likelihood of having used NRT for smoking cessation. Persons who utilize 
pharmacotherapy for smoking cessation tend to endorse greater nicotine dependence, 
more severe withdrawal from smoking, and expectations for greater difficulty quitting 
(Shiffman, Brockwell, Pillitteri, & Gitchell, 2008; Shiffman, Di Marino, & Sweeney, 
2005). There is somewhat parallel evidence that smokers with comorbid pain disorders 
are more likely to meet criteria for nicotine dependence (Zvolensky et al., 2009), and 
less confident in their ability to abstain from smoking (Hooten, Vickers, et al., 2011). 
Collectively, these data seem consistent with a reciprocal model of pain and smoking in 
which pain is hypothesized to motivate smoking and maintain tobacco dependence 
(Ditre et al., 2011). 
One explanation for our primary finding may be that persons in pain anticipate 
greater difficulty abstaining from smoking, which, in turn, makes them more likely to 
seek out and employ pharmacological interventions. Another possibility could be that 
smokers with chronic pain are simply more likely to encounter a variety of health care 
providers (possibly as a function of their underlying pain disorder) who recommend or 
prescribe pharmacotherapy for smoking cessation. Indeed, pain motivates approximately 
half of all annual physician visits in the United States (Mayo Clinic, 2001; Turk & 
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Melzack, 2011), and Clinical Practice Guidelines recommend that health care providers 
advise and assist smokers with quitting at every visit (Fiore et al., 2008). 
Exploratory analyses revealed no evidence of an association between chronic pain status 
and frequency of past attempts to quit smoking. This finding is consistent with the 
results of a previous study that found no relation between pain and self-reported desire to 
quit smoking (Hahn et al., 2006), and with reports that smokers undergoing treatment for 
pain are highly motivated to quit (Hooten et al., 2009; Hooten, Vickers, et al., 2011). 
Thus, although recurring pain may present a significant barrier to smoking cessation, 
there is no evidence to suggest that pain may reduce motivation to quit smoking or the 
likelihood of engaging a serious quit attempt.  
Several limitations of the current study bear noting. First, the cross-sectional 
nature of these findings precludes discussion of temporal precedence and any inferences 
regarding direction of causality. Second, respondents were not asked to report the 
duration of abstinence achieved when using pharmacotherapy. Therefore, these data 
cannot speak to the efficacy of pharmacotherapy for smoking cessation/reduction among 
persons with chronic pain. Third, a substantial number of respondents endorsed more 
than one type of chronic pain (55% of smokers who endorsed pain), and use of both 
nicotine patch/gum and prescription medication (30% of smokers who endorsed 
pharmacotherapy use), which may have limited our ability to differentiate between 
chronic pain sub-types and use of specific pharmacotherapies.  
Research in the area of pain and smoking has increased dramatically in recent 
years, and there is an emerging literature which suggests that complex interactions 
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between these two conditions may influence their respective treatment trajectories (Ditre 
et al., 2011). With regard to smoking cessation, it is encouraging to note that a 
subpopulation of smokers who may be expected to have greater difficulty quitting (i.e., 
those with chronic pain), appear highly receptive to utilizing first-line agents for 
smoking cessation. Indeed, these individuals may be receptive to a variety of treatment 
modalities, especially if they come to understand that continued smoking may 
exacerbate or maintain their pain. Also, given the chronic nature of both conditions, 
smokers with comorbid pain may be good candidates for a chronic disease management 
approach to treating tobacco addiction (e.g., Joseph et al., 2011). Future research should 
employ a prospective analysis of how persons with chronic pain approach smoking 
cessation (inclusive of both behavioral and pharmacological interventions), and the 
extent to which chronic pain status may predict smoking abstinence-related outcomes.  
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